Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome

NCT00348738 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Cervix Cancer

Interventions

DRUG: Erythropoietin

Sponsor

Medical University of Vienna